SCHEMBL505395

SCHEMBL505395

COC(=O)c1c(F)c(F)c(-c2ccc(C=O)cc2)c(F)c1F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
KMT2A Q03164 2/20 0.44
POLB P06746 1/20 0.44
RAB9A P51151 1/20 0.43
LMNA P02545 2/20 0.41
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
ERN1 O75460 2/20 0.39
MEN1 O00255 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP2A6 P11509 1/20 0.38
GCGR P47871 1/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25332785 0.83 SLC6A3 (0.50) ALDH1A1KMT2APOLBRAB9ALMNA
SCHEMBL29936878 0.81 ALDH1A1 (0.50) ALDH1A1KMT2APOLBRAB9ALMNA
SCHEMBL505248 0.80 LMNA (0.57) ALDH1A1KMT2ARAB9ALMNATSHR
SCHEMBL29408445 0.79 BRD4 (0.46) ALDH1A1CYP2A6BRD4DRD1
SCHEMBL505633 0.78 TSHR (0.46) ALDH1A1KMT2APOLBRAB9ALMNA
SCHEMBL29936785 0.78 L3MBTL1 (0.49) ALDH1A1KMT2APOLBRAB9ALMNA
SCHEMBL28835940 0.78 SLC6A2 (0.47) ALDH1A1KMT2APOLBRAB9ALMNA
SCHEMBL10267427 0.78 ALDH1A1 (0.41) ALDH1A1KMT2AMEN1GAAMAPT
SCHEMBL29106646 0.78 LMNA (0.58) ALDH1A1KMT2APOLBRAB9ALMNA
SCHEMBL4847292 0.77 BRD4 (0.44) ALDH1A1CYP2A6BRD4DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2414328-B1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO SA (CH) 2021-05-26 EP disclosed
EP-2414328-B1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO SA (CH) 2021-05-26 EP disclosed
US-9006454-B2 Dihydroorotate dehydrogenase inhibitors MERCK SERONO S.A. (CH) 2015-04-14 US disclosed
US-9006454-B2 Dihydroorotate dehydrogenase inhibitors MERCK SERONO S.A. (CH) 2015-04-14 US disclosed
US-9006454-B2 Dihydroorotate dehydrogenase inhibitors MERCK SERONO S.A. (CH) 2015-04-14 US disclosed
EP-2414328-A2 DIHYDROOROTATE DEHYDROGENASE INHIBITORS Merck Serono S.A. (CH) 2012-02-08 EP disclosed
US-20120028959-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO S.A. (CH) 2012-02-02 US disclosed
US-20120028959-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO S.A. (CH) 2012-02-02 US disclosed
WO-2010115736-A2 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO S.A. (CH) 2010-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028959-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS DHODH, FH, DPYD ALDH1A1 95/4885KMT2A 836/4885POLB 517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.